<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="methods-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Front Psychiatry</journal-id><journal-id journal-id-type="publisher-id">Front. Psychiatry</journal-id><journal-title-group><journal-title>Frontiers in Psychiatry</journal-title></journal-title-group><issn pub-type="epub">1664-0640</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40012712</article-id><article-id pub-id-type="pmc">PMC11861194</article-id><article-id pub-id-type="doi">10.3389/fpsyt.2025.1491410</article-id><article-categories><subj-group subj-group-type="heading"><subject>Psychiatry</subject><subj-group><subject>Study Protocol</subject></subj-group></subj-group></article-categories><title-group><article-title>Evaluating the effectiveness of integrated traditional Chinese and Western treatment based on symptom grading: a study protocol for a multi-center, randomized controlled trial of patients with depressive disorder</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Mai</surname><given-names>Jiaxi</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="fn003" ref-type="author-notes">
<sup>&#x02020;</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Zhou</surname><given-names>Tingwei</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><xref rid="fn003" ref-type="author-notes">
<sup>&#x02020;</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/2748817"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Wang</surname><given-names>Chen</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><xref rid="fn003" ref-type="author-notes">
<sup>&#x02020;</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Ye</surname><given-names>Junrong</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1015693"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/software/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Jiao</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/2748802"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Wen</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/2552115"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/software/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Pan</surname><given-names>Yuanxin</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/2161783"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/software/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Wei</surname><given-names>Yanheng</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Yuan</surname><given-names>Lexin</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Hang</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/2748823"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Shengwei</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><xref rid="aff6" ref-type="aff">
<sup>6</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/software/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Guo</surname><given-names>Jianxiong</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><xref rid="aff6" ref-type="aff">
<sup>6</sup>
</xref><xref rid="aff7" ref-type="aff">
<sup>7</sup>
</xref><xref rid="fn001" ref-type="author-notes">
<sup>*</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Xiao</surname><given-names>Aixiang</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref><xref rid="aff7" ref-type="aff">
<sup>7</sup>
</xref><xref rid="fn001" ref-type="author-notes">
<sup>*</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1213062"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib></contrib-group><aff id="aff1">
<sup>1</sup>
<institution>Department of Science and Education, Guangzhou First People&#x02019;s Hospital</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff><aff id="aff2">
<sup>2</sup>
<institution>Department of Geriatric Neuroscience Center, Affiliated Brain Hospital, Guangzhou Medical University</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff><aff id="aff3">
<sup>3</sup>
<institution>College of Nursing, Guangzhou Medical University</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff><aff id="aff4">
<sup>4</sup>
<institution>The Affiliated Brain Hospital, Guangzhou Medical University, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff><aff id="aff5">
<sup>5</sup>
<institution>Department of Nursing, Affiliated Brain Hospital, Guangzhou Medical University</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff><aff id="aff6">
<sup>6</sup>
<institution>Department of Traditional Chinese Medicine, Affiliated Brain Hospital, Guangzhou Medical University</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff><aff id="aff7">
<sup>7</sup>
<institution>Department of Chronic Diseases, Affiliated Brain Hospital, Guangzhou Medical University</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff><author-notes><fn fn-type="edited-by"><p>Edited by: Wenzhi Hao, Jinan University, China</p></fn><fn fn-type="edited-by"><p>Reviewed by: Hang Nhu Minh Tran, Hue University, Vietnam</p><p>Jiayin Ruan, Hong Kong Polytechnic University, Hong Kong SAR, China</p></fn><corresp id="fn001">*Correspondence: Aixiang Xiao, <email xlink:href="mailto:543061910@qq.com">543061910@qq.com</email>; Jianxiong Guo, <email xlink:href="mailto:jxguonet01@126.com">jxguonet01@126.com</email>
</corresp><fn fn-type="equal" id="fn003"><p>&#x02020;These authors have contributed equally to this work and share first authorship</p></fn></author-notes><pub-date pub-type="epub"><day>12</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>16</volume><elocation-id>1491410</elocation-id><history>
<date date-type="received"><day>07</day><month>9</month><year>2024</year></date>
<date date-type="accepted"><day>13</day><month>1</month><year>2025</year></date>
</history><permissions><copyright-statement>Copyright &#x000a9; 2025 Mai, Zhou, Wang, Ye, Chen, Wang, Pan, Wei, Yuan, Yang, Wu, Guo and Xiao</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Mai, Zhou, Wang, Ye, Chen, Wang, Pan, Wei, Yuan, Yang, Wu, Guo and Xiao</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><sec><title>Background</title><p>Approximately one-third of depressed individuals receive treatment globally. The application rate of traditional Chinese medicine (TCM) for treating depression globally remains relatively low. The proposed study presents a pilot trial to evaluate the effectiveness of interventions at different levels in improving depression status in community populations.</p></sec><sec><title>Methods</title><p>A randomized controlled trial will be conducted in two communities in Guangdong, China, with a follow-up period of 12 weeks. Participants will be randomly allocated to control or intervention groups. Participants in the control group will be assigned to routine care, while participants in the intervention group will receive TCM intervention measures. The participants in the intervention group will receive integrated traditional Chinese and Western treatment according to the symptom grading of depression severity. Primary outcome measurements include the Patient Health Questionnaire (PHQ-9), the Hamilton Depression Rating Scale (HAMD-17), and the Self-Rating Depression Scale (SDS). Secondary outcome measurements include the Athens Insomnia Scale (AIS), the Epworth Sleepiness Scale (ESS), the Multiple Mental Health Literacy Scale (MMHL), the Short-Form 12 (SF-12), and the Treatment Emergent Symptom Scale (TESS). The data will be collected at baseline (T1), 2 weeks after intervention (T2), 4 weeks after intervention (T3), 8 weeks after intervention (T4), and 12 weeks after intervention (T5).</p></sec><sec><title>Discussion</title><p>This study will provide an experimental basis for the effectiveness of hierarchical integrated traditional Chinese and Western medicine (ITCWM) in improving the condition of patients with different degrees of depression. At the end of the study, it is expected for the experimental group to have an improvement in depressive symptoms and sleep quality and an enhancement in mental health awareness.</p></sec><sec><title>Clinical trial registration</title><p>
<uri xlink:href="http://www.chictr.org.cn">http://www.chictr.org.cn</uri>, identifier ChiCTR2300075169.</p></sec></abstract><kwd-group><kwd>depression</kwd><kwd>integrated traditional Chinese and Western treatment</kwd><kwd>symptom grading</kwd><kwd>randomized controlled trials</kwd><kwd>protocols</kwd></kwd-group><funding-group><funding-statement>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study is funded by the Guangzhou Health Technology Project (grant numbers 2023A031002 and 20221A010031), the Guangdong Provincial Bureau of Traditional Chinese Medicine Scientific Research Project (grant number 20222179) and Guangzhou Municipal Key Discipline in Medicine (2025-2027). Funding will support staff training and the data collection of the proposed study. The funding agencies were not involved with study design, data collection, analysis, interpretation of data, writing of the manuscript, or the decision to submit the manuscript for publication.</funding-statement></funding-group><counts><fig-count count="2"/><table-count count="1"/><equation-count count="0"/><ref-count count="46"/><page-count count="9"/><word-count count="3917"/></counts><custom-meta-group><custom-meta><meta-name>section-in-acceptance</meta-name><meta-value>Public Mental Health</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1"><title>Background</title><p>Depression is a type of serious mood disorder, and severe depressive symptom would have critical impacts on individuals&#x02019; emotional stability and daily activities (<xref rid="B1" ref-type="bibr">1</xref>). In 2019, the global incidence of depressive disorder was estimated at 290 million, representing an increase of 59.28% over 1990 (<xref rid="B2" ref-type="bibr">2</xref>). Recent research in China reported an 8.29% prevalence of moderate to severe depression in 2021 (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>). From 1990 to 2017, the disability-adjusted life years (DALYs) of depression in China had increased by 36.5%, indicating a significant disease burden (<xref rid="B3" ref-type="bibr">3</xref>). Research had demonstrated that approximately 1 out of every 10 patients in primary care experience depressive symptoms, and the incidence of depression has also increased in secondary care (<xref rid="B5" ref-type="bibr">5</xref>). Mild depression can manifest as anhedonia, sadness, and feelings of worthlessness, whereas severe depression is marked by an ongoing intention to kill oneself (<xref rid="B6" ref-type="bibr">6</xref>). Therefore, depression severely limits psychosocial functioning and diminishes life quality (<xref rid="B7" ref-type="bibr">7</xref>).</p><p>Depression can be treated by using pharmacotherapy (<xref rid="B8" ref-type="bibr">8</xref>), psychological intervention (<xref rid="B9" ref-type="bibr">9</xref>), or a combination of both (<xref rid="B10" ref-type="bibr">10</xref>). Evidence from high-income countries supported the efficacy of antidepressants and psychological interventions for depression. In low- and middle-income countries (LMICs), evidence indicates effective treatment approaches for depression, including low-cost antidepressants, cognitive behavioral therapy, and combined traditional Chinese medicine (TCM) (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>). Previous findings showed that integrated traditional Chinese and Western medicine (ITCWM) enhanced treatment outcomes by combining the symptom-targeted approach of Western medicine with the holistic principles of ITCWM. A study by Zhao (<xref rid="B13" ref-type="bibr">13</xref>) reported that acupuncture as an add-on therapy to selective serotonin reuptake inhibitors (SSRIs) improved depression symptoms significantly better than SSRIs alone (<xref rid="B13" ref-type="bibr">13</xref>). A meta-analysis (<xref rid="B14" ref-type="bibr">14</xref>) showed that compared with using Western medicine alone, syndrome differentiation could improve the effect of treatment [WMD = &#x02212;2.39, CI (&#x02212;2.96, &#x02212;1.83), <italic>Z</italic> = 8.29, <italic>p</italic> &#x0003c; 0.001] (<xref rid="B14" ref-type="bibr">14</xref>).</p><p>Clinically, SSRIs are a commonly used antidepressant, and studies showed that patients would experience side effects such as weight gain (<xref rid="B15" ref-type="bibr">15</xref>), sexual dysfunction (<xref rid="B16" ref-type="bibr">16</xref>), and gastrointestinal side effects (such as nausea, vomiting, and constipation) (<xref rid="B17" ref-type="bibr">17</xref>) after using SSRIs. Side effects might have an impact on treatment adherence (<xref rid="B18" ref-type="bibr">18</xref>), and a survey reported that up to 43% of patients with major depressive disorder drop out of antidepressant treatment due to side effects (<xref rid="B19" ref-type="bibr">19</xref>). TCM is widely applied in Asia, particularly in low- and middle-income and developing countries (<xref rid="B20" ref-type="bibr">20</xref>); 13.6% of individuals with mental disorders would seek help from TCM, and our earlier investigation indicated that leading psychiatrists supported the use of TCM to alleviate depressive symptoms and side effects caused by antidepressants and that most of them had prescribed TCM (75%) and had recommended TCM to junior psychiatrists (65%) (<xref rid="B21" ref-type="bibr">21</xref>). Therefore, an integrated traditional Chinese and Western approach is expected to provide a new direction of managing depression by maintaining medication, increasing treatment adherence, and reducing side effects, concurrently. Although Western medicine has accumulated experience in treating depression, TCM has made great progress in treating depression. By reviewing the literature, we found that comprehensive health interventions based on TCM aimed at educating patients and changing their lifestyle, including exercise (e.g., Tai Chi and Qigong), diet therapy, sleep&#x02013;wake schedule, psychological management based on TCM theory, and meridian and collateral management (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B22" ref-type="bibr">22</xref>). Treating depression by TCM has significant effects with less toxic side effects or relapse (<xref rid="B23" ref-type="bibr">23</xref>). Studies had demonstrated that TCM, particularly herbal medicine and acupuncture, had significant effects in alleviating depressive symptoms. A meta-analysis by Ching et&#x000a0;al. (<xref rid="B24" ref-type="bibr">24</xref>) reported that TCM-based treatments were effective in reducing depression severity, with fewer side effects compared to using Western medicine alone (MD: &#x02212;8.73, 95% CI: &#x02212;16.64, &#x02212;0.79) (<xref rid="B24" ref-type="bibr">24</xref>). Moreover, clinical evidence indicated that the combined therapy of ginger-isolated moxibustion and escitalopram achieved a remarkably effective rate and reduced relapse rates (<xref rid="B25" ref-type="bibr">25</xref>). Integrated traditional Chinese and Western treatment significantly optimizes the treatment effect and improves the prognosis, especially in LMICs. Additionally, our preliminary investigation discovered that leading psychiatrists advocate using TCM (<xref rid="B23" ref-type="bibr">23</xref>). Thus, exploring the combination of traditional Chinese and Western medicine in treating depression to leverage the advantages of TCM is necessary.</p><p>This policy-supported study aims to explore a new depression prevention and treatment mode to promote patient recovery and reduce depression recurrence. This mode adds TCM elements to improve the therapeutic effect. Simultaneously, according to the different depression levels in patients, multi-level ITCM interventions are expected to improve depression. We recruited a psychiatric treatment team to consult the feasibility and acceptability of the proposed program according to the Integrative Chinese and Western Medicine guidelines issued by China Association of Chinese Medicine (<ext-link xlink:href="https://www.cacm.org.cn/" ext-link-type="uri">https://www.cacm.org.cn/</ext-link>) (<xref rid="B26" ref-type="bibr">26</xref>), the largest Chinese medicine academic association supervised by the National TCM Administration. Finally, experts had reached the consensus of a proposed model after discussion.</p><p>We propose a multi-center study to evaluate the effectiveness of hierarchical integrated traditional Chinese and Western medicine (ITCWM) care in depression patients using a randomized controlled trial design.</p></sec><sec id="s2"><title>Objectives</title><p>Based on empirical findings, a program has been developed to improve the depressive state of patients with different degrees of depression using ITCWM. This study intends to evaluate the effectiveness of integrated traditional Chinese and Western treatment in improving depression in patients with different depression levels.</p></sec><sec id="s3"><title>Methods</title><sec id="s3_1"><title>Trial design</title><p>The proposed program is a multi-center, exploratory, double-blind, parallel randomized controlled trial (RCT) with a follow-up period of 12 weeks. All stages will be conducted by SPIRIT reporting guidelines (<xref rid="B27" ref-type="bibr">27</xref>). Treatments administered will be allocated randomly according to a 1:1 ratio using an online random-number generator of statistic software by a research assistant who is not involved in assessment and intervention. The block size for randomization will be 4 to ensure balanced group allocation. To maintain allocation concealment and reduce bias, the randomization sequence will be generated by an independent research assistant who is not involved in participant recruitment or data collection. Opaque and sealed envelopes will be prepared according to the randomization sequence and provided to the patients by the principal investigator or research assistants in the community. Then, research assistants would be responsible for monitoring participants&#x02019; engagement and adherence to the intervention protocol.</p></sec><sec id="s3_2"><title>Study settings and participants</title><p>This trial will be conducted in two community health service centers with similar administrative conditions in Liwan District, Guangzhou. Simultaneously, referral support will be accepted from the Affiliated Brain Hospital of Guangzhou Medical University. Ethical approval was obtained from the Institutional Review Committee of Guangzhou Medical University. This study will be conducted with the consent of hospital executives. Before allocation, informed consent will be obtained from all participants.</p></sec><sec id="s3_3"><title>Eligibility criteria</title><sec id="s3_3_1"><title>Inclusion criteria</title><list list-type="alpha-lower"><list-item><p>Comply with the diagnostic criteria for depressive episodes in the International Classification and Diagnostic Standards of Diseases (<xref rid="B28" ref-type="bibr">28</xref>).</p></list-item><list-item><p>Aged 18 and 70 years.</p></list-item><list-item><p>The score of PHQ-9 is 5 or above.</p></list-item><list-item><p>Participants are informed and signed the informed consent form voluntarily.</p></list-item></list></sec><sec id="s3_3_2"><title>Exclusion criteria</title><list list-type="alpha-lower"><list-item><p>Pregnant women and lactating women.</p></list-item><list-item><p>Severe cognitive impairment. The cognitive level is evaluated using the Minimum Mental State Examination (MMSE). The MMSE is a paper&#x02010;based test with a maximum score of 30, with lower scores indicating more severe cognitive problems. The cutoff point for normal cognitive function is typically set at 24 (<xref rid="B29" ref-type="bibr">29</xref>).</p></list-item><list-item><p>Those with severe heart, liver, kidney disease, and other systemic diseases requiring treatment.</p></list-item></list></sec></sec><sec id="s3_3a"><title>Trial status</title><p>Client recruitment started on 1 October 2023 and ended in July 2024.</p></sec><sec id="s3_4"><title>Interventions</title><p>Participants will be randomly assigned to an intervention or a control group. The flowchart of this study is presented in <xref rid="f1" ref-type="fig">
<bold>Figure&#x000a0;1</bold>
</xref>. The control group will receive routine care, while the intervention group will receive special ITCM intervention measures for 12 weeks. The participants included in the intervention group will undergo intervention according to <xref rid="f2" ref-type="fig">
<bold>Figure&#x000a0;2</bold>
</xref>.</p><fig position="float" id="f1"><label>Figure&#x000a0;1</label><caption><p>The study&#x02019;s flowchart.</p></caption><graphic xlink:href="fpsyt-16-1491410-g001" position="float"/></fig><fig position="float" id="f2"><label>Figure&#x000a0;2</label><caption><p>Integrated traditional Chinese and Western treatment graded intervention flowchart.</p></caption><graphic xlink:href="fpsyt-16-1491410-g002" position="float"/></fig><p>According to PHQ-9, participants will be divided into three levels: mild, moderate, and severe, and will receive corresponding interventions. The intervention strategies are dynamically adjusted based on the evaluation of time nodes. <xref rid="T1" ref-type="table">
<bold>Table&#x000a0;1</bold>
</xref> presents a detailed study&#x02019;s graded intervention.</p><table-wrap position="float" id="T1"><label>Table&#x000a0;1</label><caption><p>The details of graded interventions applied to the groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1"/><th valign="middle" colspan="2" align="center" rowspan="1">Group allocation</th><th valign="middle" colspan="3" align="center" rowspan="1">Intervention group</th><th valign="bottom" align="center" rowspan="1" colspan="1">Control group</th></tr></thead><tbody><tr><td valign="middle" rowspan="9" align="center" colspan="1">Intervention</td><td valign="top" colspan="2" align="center" rowspan="1">PHQ-9<break/>(score)</td><td valign="top" align="center" rowspan="1" colspan="1">Mild<break/>(5&#x02013;9)</td><td valign="top" align="center" rowspan="1" colspan="1">Moderate<break/>(10&#x02013;14)</td><td valign="top" align="center" rowspan="1" colspan="1">Severe<break/>(15&#x02013;27)</td><td valign="top" align="center" rowspan="1" colspan="1">Positive<break/>(5&#x02013;27)</td></tr><tr><td valign="middle" rowspan="3" align="center" colspan="1">Section A</td><td valign="bottom" align="left" rowspan="1" colspan="1">1. Acupuncture and foot bath</td><td valign="middle" rowspan="3" align="center" colspan="1">&#x0221a;</td><td valign="middle" rowspan="3" align="center" colspan="1">&#x0221a;</td><td valign="middle" rowspan="3" align="center" colspan="1">&#x0221a;</td><td valign="middle" rowspan="8" align="center" colspan="1">1. Health education<break/>2. Psychological counseling</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1">2. Health education</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1">3. Psychological counseling</td></tr><tr><td valign="middle" rowspan="3" align="center" colspan="1">Section B</td><td valign="bottom" align="left" rowspan="1" colspan="1">1. Follow-up</td><td valign="bottom" rowspan="3" align="center" colspan="1">
</td><td valign="middle" rowspan="3" align="center" colspan="1">&#x0221a;</td><td valign="middle" rowspan="3" align="center" colspan="1">&#x0221a;</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1">2. Referral support</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1">3. Drug compliance</td></tr><tr><td valign="middle" rowspan="2" align="center" colspan="1">Section C</td><td valign="bottom" align="left" rowspan="1" colspan="1">1. Referral support</td><td valign="bottom" rowspan="2" align="center" colspan="1">
</td><td valign="bottom" rowspan="2" align="center" colspan="1">
</td><td valign="bottom" rowspan="2" align="center" colspan="1">&#x0221a;</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1">2. Family members engagement</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1">Time</td><td valign="bottom" colspan="6" align="center" rowspan="1">2, 4, 8, and 12 weeks</td></tr></tbody></table></table-wrap><sec id="s3_4_1"><title>Section A</title><p>1. Therapeutic acupuncture</p><p>Acupuncture protocol was according to the Standards for Reporting Interventions in Controlled Trials of Acupuncture (STRICTA) (<xref rid="B30" ref-type="bibr">30</xref>). A total of three licensed TCM practitioners with &#x02265;5 years&#x02019; work experience are responsible for selecting the acupoints. All TCM practitioners will receive consistency training according to study protocols. The selection of acupoints will be based on the established TCM principles and tailored to each participant&#x02019;s specific presentation of depression.</p><p>First, the TCM practitioner would conduct a thorough evaluation of each participant, including their symptoms, medical history, and overall health status, to determine the most appropriate acupoints. Furthermore, based on this assessment, acupoints will be selected from well-established protocols for depression treatment in TCM. The primary acupoints include Baihui (GV 20), Qihai (CV 6), Neiguan (PC 6), Shenmen (HT 7), Guanyuan (CV 4), Taichong (LR 3), Sanyinjiao (SP 6), and Zusanli (ST 36). When performing manual acupuncture, the needle should be inserted slowly and retained for 30 min after getting qi. The needle type is a sterile disposable stainless-steel needle size of 0.35 &#x000d7; 25 mm. Acupuncture courses are scheduled three times a week for 30 min each (<xref rid="B31" ref-type="bibr">31</xref>).</p><p>2. TCM foot bath</p><p>The participants will sit on a chair with the water temperature at 40&#x02103;. The water depth is 10 cm above the ankle.</p><p>3. Health education</p><p>Health education information can be regularly released via online psychological forums and WeChat official accounts. Simultaneously, promotional brochures will be distributed to help participants understand depression-related knowledge. Health education focuses primarily on depression, including etiology, pathogenesis, clinical manifestations, prognosis, treatment, and rehabilitation guidance. The focus is on the effects of antidepressants, adverse reactions, and management of antidepressants.</p><p>4. Psychological counseling</p><p>Participants initiated in-person psychological counseling with trained nurses. This approach is based on the assumption that communicating with a non-judgmental and empathic professional enables individuals to take a more positive view of themselves and their lives (<xref rid="B32" ref-type="bibr">32</xref>).</p></sec><sec id="s3_4_2"><title>Section B</title><p>1. Follow-up</p><p>All participants will be subjected to follow-up at 2, 4, 8, and 12 weeks. The follow-up includes physical, psychological, and social conditions. The medication status, referral status, recurrence status, and economic burden will be collected using self-made scales.</p><p>2. Referral support</p><p>For participants with mild (PHQ-9 score 5&#x02013;9) and moderate depression (PHQ-9 score 10&#x02013;14), the experimental community will complete evaluation, treatment, and follow-up according to the intervention plan in the community. If the condition worsens or the treatment conditions cannot be met, the participants can be transferred to a superior hospital. Moreover, the participants will be transferred to primary healthcare for continued rehabilitation after treatment and recovery at the superior hospital.</p><p>3. Basic medication</p><p>SSRIs, for example, sertraline and fluoxetine, will be used to alleviate depressive symptoms (<xref rid="B33" ref-type="bibr">33</xref>). When insomnia occurs, combining zolpidem, zopiclone, and short-acting benzodiazepine sedatives could improve sleep. Additionally, when it comes to medication for treating physical diseases, maintaining a consistent type and dosage of medication can help to reduce confounding. To ensure consistency in medication use, all participants receiving SSRIs would follow a uniform prescribing protocol, including dosage adjustments and monitoring by the same team of qualified clinicians. Additionally, participants&#x02019; medication regimens would be closely tracked, and any changes would be documented and accounted for in the statistical analysis to isolate the effects of the integrated traditional Chinese and Western intervention. During the study, antidepressant medications would be applied based on the guideline for primary healthcare service of major depressive disorder (<xref rid="B34" ref-type="bibr">34</xref>) introduced by the Chinese Medical Association.</p></sec><sec id="s3_4_3"><title>Section C</title><p>1. Referral support</p><p>Participants with severe depression (PHQ-9 score 15&#x02013;27) exhibit suicidal or homicidal thoughts or intentions after completing assessments regarding mental, suicide risk, and violence. Once a participant is evaluated as experiencing severe depression (PHQ-9 &#x02265;15) and exhibited suicidal or homicidal thoughts, they would be referred to specific psychiatric hospitals for close monitoring and treatment. In addition, for participants with severe depression but did not exhibit high-risk behaviors, our research team would provide ongoing monitoring and support throughout the study period.</p><p>2. Family engagement</p><p>2.1 Communication with family: Participants will be encouraged to communicate their feelings and experiences with their families. Encouraging family members to understand patients&#x02019; conditions, involving them in treatment, and urging them to provide support can help the participants.</p><p>2.2 A brochure is developed for the family-enhanced depression intervention. The manualized intervention is delivered by nurses in primary care and consisted of up to 12 sessions delivered in the primary care clinic over 4 weeks. A participant&#x02019;s family member would be encouraged to participate in all sessions of the intervention. The intervention included psychoeducation regarding depression and treatment, self-management support (medication adherence and questions with medications), behavioral activation, guidance on primary care physician visits, and relapse and prevention planning. A family member can participate in treatment sessions as part of the intervention to support one or more of these aspects of depression care (<xref rid="B35" ref-type="bibr">35</xref>).</p><p>If a participant misses any treatment, the research assistants will contact them.</p></sec></sec><sec id="s3_5"><title>Routine nursing care during intervention</title><p>Participants and their caregivers received routine care and health education during the intervention and follow-up period. Treatments include observation, pharmacological therapies, and follow-up at the same time as the intervention group.</p></sec></sec><sec id="s4"><title>Outcomes</title><sec id="s4_1"><title>Primary outcomes</title><p>The PHQ-9 would be used to evaluate symptoms of depression during the past 2 weeks. The total score ranges from 0 to 27 with five categories of severity: minimal (0&#x02013;4), mild (5&#x02013;9), moderate (10&#x02013;14), moderately severe (15&#x02013;19), and severe (20&#x02013;27) (<xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B37" ref-type="bibr">37</xref>).</p><p>The HAMD-17 (<xref rid="B38" ref-type="bibr">38</xref>) is used to assess the severity of depressive symptoms in participants. This scale has good reliability and validity and is widely used to assess the severity of depressive symptoms. The depression severity is classified according to the total score of HAMD-17: 0&#x02013;7 points for no depressive symptoms, 8&#x02013;17 points for mild depressive symptoms, 18&#x02013;24 points for moderate depressive symptoms, and &#x0003e;24 points for severe depressive symptoms.</p><p>The SDS (<xref rid="B39" ref-type="bibr">39</xref>) has 20 items designed on the was basic of diagnostic criteria for depression. Participants rate each item about how they have felt during the past several days. The raw sum score of the SDS ranges from 20 to 80, but results are usually presented as the SDS Index, obtained by converting the raw score to a 100-point scale.</p></sec><sec id="s4_2"><title>Secondary outcomes</title><p>The AIS is a self-assessment psychological measurement instrument aiming to quantify sleep difficulties according to the ICD-10 standard. The scale consisted of eight items. The total score ranges from 0 to 21. The questions are scored from 0 to 3 according to the Likert scale, and a total score &#x02265;6 indicates insomnia. High scores indicate severe insomnia symptoms (<xref rid="B40" ref-type="bibr">40</xref>).</p><p>The ESS (<xref rid="B41" ref-type="bibr">41</xref>) would be used to assess daytime sleepiness. This questionnaire consists of eight self-rated items, each scored from 0 to 3, which measure participants&#x02019; habitual &#x0201c;likelihood of dozing or falling asleep&#x0201d; in common situations of daily living. The final score was the sum of individual items (scores 0&#x02013;24). Values &#x0003e;&#x02009;10 are considered excessive daytime sleepiness, whereas values &#x0003e;&#x02009;15 are considered severe sleepiness.</p><p>The MMHL, developed by Jung et&#x000a0;al. (<xref rid="B42" ref-type="bibr">42</xref>) in 2012, would be used to measure adults&#x02019; mental health literacy level. Zhijun et&#x000a0;al. (<xref rid="B43" ref-type="bibr">43</xref>) conducted the 22-item Chinese translation, including the following three dimensions: mental health knowledge, beliefs, and resources. The total score ranges from 0 to 22. Higher scores suggest a higher level of mental health literacy.</p><p>The SF-12 is a 12-item instrument designed to measure general health-related quality of life (HRQoL) (<xref rid="B44" ref-type="bibr">44</xref>). Answers provide two summary scores, the mental component scale (MCS) and the physical component scale (PCS), reflecting the individual&#x02019;s perceived mental and physical health. Scores range from 0 to 100 for each component scale. A score of 50 or more indicates a positive perception of health, whereas a score below 50 indicates a negative perception.</p><p>The TESS (<xref rid="B45" ref-type="bibr">45</xref>) was developed by the National Institute of Mental Health (NIMH) in 1973. TESS includes common adverse symptoms and signs and numerous laboratory test results. This scale has the advantage of allowing the symptoms of each system to be fully identified.</p></sec><sec id="s4_3"><title>Sample size</title><p>This RCT calculates sample size by comparing the mean of two samples. The HAMD-17 score is used as the outcome indicator for observation. According to a previous study (<xref rid="B46" ref-type="bibr">46</xref>), the mean of HAMD-17 was 13.3 in the control group, with a standard deviation of 3.6, while the mean of HAMD-17 was 16.5 in the intervention group, with a standard deviation of 4.6. PASS 15.0 version was used to estimate the target sample size, 1 &#x02212; &#x003b2; = 0.9, &#x003b1; = 0.05. Lost and refused visits were considered, and a 20% dropout rate was calculated. Therefore, the target sample size for each group will be 47 participants. A total of 94 participants will be targeted.</p></sec><sec id="s4_4"><title>Recruitment</title><p>Participants who meet the screening requirements in this study will be invited. Every participant has finished the initial step of evaluation, which is a regular process throughout the early phases of the investigation. The participants will be provided with all the necessary information about the study. The research team will inform patients of the research purpose and process and fully respect the rights of the participants.</p></sec><sec id="s4_5"><title>Allocation</title><p>The research sites for the experiment are two community health service centers with similar administrative conditions in Liwan District, Guangzhou. Consecutive eligible participants will be collected to reduce selection bias until the number of cases assigned is completed.</p></sec><sec id="s4_6"><title>Blinding</title><p>This is a double-blind study. The concealment and blinding of the assignment will be assured since the assistants performing the assessment will be unaware of the subject&#x02019;s group assignment. This study&#x02019;s results will be evaluated by trained research assistants. Participants will not be informed of the pattern of research allocation. During the intervention, the veil of blinding will be lifted if severe complications and adverse events occur. During the trial, both participants and research assistants conducting psychological assessment would not be disclosed about group allocation. Furthermore, research assistants conducting interventions would be required to only implement psychological counseling while not disclosing group allocation.</p></sec><sec id="s4_7"><title>Data collection and management</title><p>The impacts of traditional Chinese and Western medicine intervention will be collected at baseline (T1), 2 weeks after intervention (T2), 4 weeks after intervention (T3), 8 weeks after intervention (T4), and 12 weeks after intervention (T5) to dynamically adjust intervention measures based on intervention effectiveness. Other outcomes, including adverse events, attendance, and attrition rates, will be continuously collected weekly from baseline. Research assistants will be trained to ensure consistent results. To ensure an adequate follow-up rate, we will maintain regular contact with patients after giving informed consent (every 2 weeks). After the measurement, data will be double-checked for consistency, accuracy, and integrity. Raw data will be anonymized and stored on a secured computer database. According to the regulation governing research activities, data will be monitored by Department of Research Project Administration of GZ. Research data could only be accessed by authorized members of the trial team. After obtaining permission from the project investigator (AX), anonymized trial data would be shared to enable further prospective meta-analyses.</p></sec><sec id="s4_8"><title>Statistical methods</title><p>SPSS 25.0 statistical analysis software will be used for statistical analysis. The continuous variable will be expressed in mean &#x000b1; standard deviation (<italic>&#x003c7;</italic> &#x000b1; SD) and frequency (%). The SNK-q test will be used to compare the two groups, and the analysis of variance will be used to compare the measurement data at multiple time points. All <italic>p</italic>-values are two-sided and reported as statistically significant based on a significance level 0.05. We shall study protocol non-adherence during the process analysis and will impute missing data by multiple imputation.</p></sec><sec id="s4_9"><title>Monitoring</title><p>All adverse events spontaneously reported by participants or observed by the research team will be recorded. A research assistant will be assigned to conduct a biweekly review of the study progress and any adverse events of this study.</p></sec><sec id="s4_10"><title>Ethical issues</title><p>The trial will comply with the Helsinki Declaration of Human Rights principles. This research has obtained ethical approval from the Ethics Committee of the Affiliated Brain Hospital of Guangzhou Medical University (approval number: 2023062).</p></sec><sec id="s4_11"><title>Modification and inquiry</title><p>Any modification or inquiry regarding the study will be communicated to the Ethic Committee of the Affiliated Brain Hospital of Guangzhou Medical University.</p></sec><sec id="s4_12"><title>Consent</title><p>Written informed consent forms will be collected from participants before the allocation by research assistants. Participants will be informed that they can accept or refuse participation in the study. On the consent form, participants will be asked if they agree to use their data if they withdraw from the trial. Participants must also obtain permission from the research team to share relevant data with other reasonably purposeful research teams and regulatory agencies. If a participant&#x02019;s condition suddenly deteriorates or severe adverse reactions occur during the experiment, the experiment will be immediately halted, and researchers will administer active medical measures. If participants have a high risk of suicide, our researchers will also provide preventive measures. Participants will be informed that they can accept or refuse to participate in the study.</p></sec><sec id="s4_13"><title>Confidentiality</title><p>The participant&#x02019;s personal data, including name, address, and phone number, included in the consent form and case report form, will be anonymized using the study ID number and stored in a secured database. The research data will be monitored by the Research Project Management Department of Guangzhou Medical University, and only authorized members of the experimental team can access it.</p></sec><sec id="s4_14"><title>Post&#x02212;trial care</title><p>If the study demonstrates no negative effects, participants in the control groups will be invited to participate in the integrated traditional Chinese and Western treatment based on the symptom grading program after the study time frame.</p></sec><sec id="s4_15"><title>Access to data</title><p>The datasets will be available from the corresponding author upon reasonable request.</p></sec><sec id="s4_16"><title>Dissemination</title><p>This study&#x02019;s results will be disseminated through peer-reviewed publications and conference presentations. After completing the trial, the results will only be used for the proposal. This plan can be publicly accessed via the above clinical trial registration platform. The research results will also be presented in peer-reviewed scientific journals and published at academic conferences.</p></sec><sec id="s4_17"><title>Study quality control</title><p>The tools utilized in this study are subjected to reliability and efficiency tests. All research assistants will receive consistency training to conduct appropriate assessments and review questionnaires to improve homogeneity. Additionally, the researchers are trained on how to assess and implement the interventions and are allowed to check their quality each month.</p></sec></sec><sec sec-type="discussion" id="s5"><title>Discussion</title><p>This protocol proposes an exploratory RCT to evaluate the effectiveness of ITCWM care in improving the depressive status of patients with different degrees of depression in Guangdong, China. This trial course will comprise a 12-week intervention and a 12-week follow-up period.</p></sec></body><back><ack><title>Acknowledgments</title><p>We would like to acknowledge the medical staff of the Affiliated Brain Hospital of Guangzhou Medical University (GZ) and Guangzhou First People&#x02019;s Hospital (GZ) for their dedication in the integrated Traditional Chinese and Western program.</p></ack><fn-group><title>Abbreviations</title><fn fn-type="abbr" id="abbrev1"><p>ITCWM, integrated traditional Chinese and Western medicine; DALYs, disability-adjusted life years; TCM, traditional Chinese medicine; PHQ-9, Patient Health Questionnaire; SSRIs, selective serotonin reuptake inhibitors; MMSE, Minimum Mental State Examination; AIS, Athens Insomnia Scale; MMHL, Multiple Mental Health Literacy Scale; LMICs, low and middle-income countries; RCT, randomized controlled trial; HAMD-17, Hamilton Depression Rating Scale; SDS, Self-Rating Depression Scale; ESS, Epworth Sleepiness Scale; SF-12, Short-Form 12; HRQoL, health-related quality of life; MCS, mental component scale; PCS, physical component scale; TESS, Treatment Emergent Symptom Scale; NIMH, National Institute of Mental Health.</p></fn></fn-group><sec sec-type="ethics-statement" id="s11"><title>Ethics statement</title><p>The studies involving humans were approved by Ethic Committee of the Affiliated Brain Hospital of Guangzhou Medical University. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p></sec><sec sec-type="author-contributions" id="s12"><title>Author contributions</title><p>JM: Conceptualization, Investigation, Methodology, Project administration, Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing. TZ: Conceptualization, Data curation, Formal analysis, Investigation, Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing. CW: Conceptualization, Data curation, Formal analysis, Investigation, Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing. JY: Writing &#x02013; review &#x00026; editing, Conceptualization, Formal analysis, Methodology, Project administration, Software, Supervision.&#x000a0;JC:&#x000a0;Conceptualization, Investigation, Methodology, Project&#x000a0;administration, Writing &#x02013; review &#x00026; editing. WW: Conceptualization, Investigation, Methodology, Software, Writing &#x02013; review &#x00026; editing. YP: Investigation, Methodology, Software, Writing &#x02013; review &#x00026; editing. YW: Funding acquisition, Investigation, Methodology, Supervision, Writing &#x02013; review &#x00026; editing. LY: Investigation, Methodology, Project administration, Writing &#x02013; review &#x00026; editing. HY: Project administration, Supervision, Writing &#x02013; review &#x00026; editing, Funding acquisition, Investigation, Methodology. SW: Methodology, Project administration, Software, Supervision, Writing &#x02013; review &#x00026; editing. JG: Conceptualization, Investigation, Methodology, Project administration, Supervision, Writing &#x02013; review &#x00026; editing. AX: Conceptualization, Data curation, Formal analysis, Funding acquisition, Methodology, Project administration, Supervision, Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing.</p></sec><sec sec-type="COI-statement" id="s14"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="disclaimer" id="s15"><title>Publisher&#x02019;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="webpage">
<person-group person-group-type="author">
<collab>National Institute of Mental Health</collab>
</person-group>. <article-title>Depression [EB/OL</article-title>(<year>2023</year>). Available online at: <uri xlink:href="https://www.nimh.nih.gov/health/topics/depressionpart_2256">https://www.nimh.nih.gov/health/topics/depressionpart_2256</uri> (Accessed <date-in-citation content-type="access-date">November 18, 2023</date-in-citation>).</mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rong</surname><given-names>J</given-names></name>
<name><surname>Cheng</surname><given-names>P</given-names></name>
<name><surname>Li</surname><given-names>D</given-names></name>
<name><surname>Wang</surname><given-names>X</given-names></name>
<name><surname>Zhao</surname><given-names>D</given-names></name>
</person-group>. <article-title>Global, regional, and national temporal trends in prevalence for depressive disorders in older adults, 1990-2019: An age-period-cohort analysis based on the global burden of disease study 2019</article-title>. <source>Ageing Res Rev</source>. (<year>2024</year>) <volume>100</volume>:<fpage>102443</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.arr.2024.102443</pub-id>
<pub-id pub-id-type="pmid">39097004</pub-id>
</mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>J</given-names></name>
<name><surname>Zhao</surname><given-names>Z</given-names></name>
<name><surname>Yang</surname><given-names>J</given-names></name>
<name><surname>Wang</surname><given-names>L</given-names></name>
<name><surname>Zhang</surname><given-names>M</given-names></name>
<name><surname>Zhou</surname><given-names>M</given-names></name>
</person-group>. <article-title>The association between depression and all-cause, cause-specific mortality in the Chinese population - China, 2010-2022</article-title>. <source>China CDC Wkly</source>. (<year>2024</year>) <volume>6</volume>:<page-range>1022&#x02013;7</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.46234/ccdcw2024.212</pub-id>
</mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lu</surname><given-names>J</given-names></name>
<name><surname>Xu</surname><given-names>X</given-names></name>
<name><surname>Huang</surname><given-names>Y</given-names></name>
<name><surname>Li</surname><given-names>T</given-names></name>
<name><surname>Ma</surname><given-names>C</given-names></name>
<name><surname>Xu</surname><given-names>G</given-names></name>
<etal/>
</person-group>. <article-title>Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study</article-title>. <source>Lancet Psychiatry</source>. (<year>2021</year>) <volume>8</volume>:<page-range>981&#x02013;90</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/S2215-0366(21)00251-0</pub-id>
</mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>McCarron</surname><given-names>RM</given-names></name>
<name><surname>Shapiro</surname><given-names>B</given-names></name>
<name><surname>Rawles</surname><given-names>J</given-names></name>
<name><surname>Luo</surname><given-names>J</given-names></name>
</person-group>. <article-title>Depression</article-title>. <source>Ann Internal Med</source>. (<year>2021</year>) <volume>174</volume>:<page-range>ITC65&#x02013;80</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.7326/AITC202105180</pub-id>
</mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Belmaker</surname><given-names>RH</given-names></name>
<name><surname>Agam</surname><given-names>G</given-names></name>
</person-group>. <article-title>Major depressive disorder</article-title>. <source>New Engl J Med</source>. (<year>2008</year>) <volume>358</volume>:<fpage>55</fpage>&#x02013;<lpage>68</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1056/NEJMra073096</pub-id>
<pub-id pub-id-type="pmid">18172175</pub-id>
</mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Alexopoulos</surname><given-names>GS</given-names></name>
</person-group>. <article-title>Depression in the elderly</article-title>. <source>Lancet (London England)</source>. (<year>2005</year>) <volume>365</volume>:<page-range>1961&#x02013;70</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/S0140-6736(05)66665-2</pub-id>
</mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Smith-Apeldoorn</surname><given-names>SY</given-names></name>
<name><surname>Veraart</surname><given-names>JK</given-names></name>
<name><surname>Spijker</surname><given-names>J</given-names></name>
<name><surname>Kamphuis</surname><given-names>J</given-names></name>
<name><surname>Schoevers</surname><given-names>RA</given-names></name>
</person-group>. <article-title>Maintenance ketamine treatment for depression: a systematic review of efficacy, safety, and tolerability</article-title>. <source>Lancet Psychiatry</source>. (<year>2022</year>) <volume>9</volume>:<page-range>907&#x02013;21</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/S2215-0366(22)00317-0</pub-id>
</mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Watt</surname><given-names>JA</given-names></name>
<name><surname>Goodarzi</surname><given-names>Z</given-names></name>
<name><surname>Veroniki</surname><given-names>AA</given-names></name>
<name><surname>Nincic</surname><given-names>V</given-names></name>
<name><surname>Khan</surname><given-names>PA</given-names></name>
<name><surname>Ghassemi</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Comparative efficacy of interventions for reducing symptoms of depression in people with dementia: systematic review and network meta-analysis</article-title>. <source>BMJ (Clinical Res ed)</source>. (<year>2021</year>) <volume>372</volume>:<fpage>n532</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1136/bmj.n532</pub-id>
</mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>X</given-names></name>
<name><surname>Teng</surname><given-names>T</given-names></name>
<name><surname>Zhang</surname><given-names>Y</given-names></name>
<name><surname>Cuijpers</surname><given-names>P</given-names></name>
<name><surname>Hetrick</surname><given-names>SE</given-names></name>
<name><surname>Weisz</surname><given-names>JR</given-names></name>
<etal/>
</person-group>. <article-title>Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis</article-title>. <source>Lancet Psychiatry</source>. (<year>2020</year>) <volume>7</volume>:<fpage>581</fpage>&#x02013;<lpage>601</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/S2215-0366(20)30137-1</pub-id>
<pub-id pub-id-type="pmid">32563306</pub-id>
</mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Brown</surname><given-names>JVE</given-names></name>
<name><surname>Wilson</surname><given-names>CA</given-names></name>
<name><surname>Ayre</surname><given-names>K</given-names></name>
<name><surname>Robertson</surname><given-names>L</given-names></name>
<name><surname>South</surname><given-names>E</given-names></name>
<name><surname>Molyneaux</surname><given-names>E</given-names></name>
<etal/>
</person-group>. <article-title>Antidepressant treatment for postnatal depression</article-title>. <source>Cochrane Database Syst Rev</source>. (<year>2021</year>) <volume>2</volume>:<fpage>Cd013560</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1002/14651858.CD013560.pub2</pub-id>
<pub-id pub-id-type="pmid">33580709</pub-id>
</mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mekonen</surname><given-names>T</given-names></name>
<name><surname>Chan</surname><given-names>GCK</given-names></name>
<name><surname>Connor</surname><given-names>JP</given-names></name>
<etal/>
</person-group>. <article-title>Estimating the global treatment rates for depression: A systematic review and meta-analysis</article-title>. <source>J Affect Disord</source>. (<year>2021</year>) <volume>295</volume>:<page-range>1234&#x02013;42</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jad.2021.09.038</pub-id>
</mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>B</given-names></name>
<name><surname>Li</surname><given-names>Z</given-names></name>
<name><surname>Shi</surname><given-names>C</given-names></name>
<name><surname>Liu</surname><given-names>Y</given-names></name>
<name><surname>Sun</surname><given-names>Y</given-names></name>
<name><surname>Li</surname><given-names>B</given-names></name>
<etal/>
</person-group>. <article-title>Acupuncture as add-on therapy to SSRIs can improve outcomes of treatment for anxious depression: subgroup analysis of the AcuSDep trial</article-title>. <source>Neuropsychiatr Dis Treat</source>. (<year>2024</year>) <volume>20</volume>:<page-range>1049&#x02013;64</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.2147/NDT.S446034</pub-id>
</mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kou</surname><given-names>MJ</given-names></name>
<name><surname>Chen</surname><given-names>JX</given-names></name>
</person-group>. <article-title>Integrated traditional and Western medicine for treatment of depression based on syndrome differentiation: a meta-analysis of randomized controlled trials based on the Hamilton depression scale</article-title>. <source>J Tradi Chin Med</source>. (<year>2012</year>) <volume>32</volume>:<fpage>1</fpage>&#x02013;<lpage>5</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/S0254-6272(12)60023-5</pub-id>
</mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Alonso-Pedrero</surname><given-names>L</given-names></name>
<name><surname>Bes-Rastrollo</surname><given-names>M</given-names></name>
<name><surname>Marti</surname><given-names>A</given-names></name>
</person-group>. <article-title>Effects of antidepressant and antipsychotic use on weight gain: A systematic review</article-title>. <source>Obes Reviews: an Off J Int Assoc Study Obes</source>. (<year>2019</year>) <volume>20</volume>:<page-range>1680&#x02013;90</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/obr.v20.12</pub-id>
</mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rothmore</surname><given-names>J</given-names></name>
</person-group>. <article-title>Antidepressant-induced sexual dysfunction</article-title>. <source>Med J Aust</source>. (<year>2020</year>) <volume>212</volume>:<page-range>329&#x02013;34</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.5694/mja2.v212.7</pub-id>
</mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Oliva</surname><given-names>V</given-names></name>
<name><surname>Lippi</surname><given-names>M</given-names></name>
<name><surname>Paci</surname><given-names>R</given-names></name>
<name><surname>Del Fabro</surname><given-names>L</given-names></name>
<name><surname>Delvecchio</surname><given-names>G</given-names></name>
<name><surname>Brambilla</surname><given-names>P</given-names></name>
<etal/>
</person-group>. <article-title>Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: A systematic review and meta-analysis</article-title>. <source>Prog Neuropsychopharmacol Biol Psychiatry</source>. (<year>2021</year>) <volume>109</volume>:<fpage>110266</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.pnpbp.2021.110266</pub-id>
<pub-id pub-id-type="pmid">33549697</pub-id>
</mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hung</surname><given-names>CI</given-names></name>
</person-group>. <article-title>Factors predicting adherence to antidepressant treatment</article-title>. <source>Curr Opin Psychiatry</source>. (<year>2014</year>) <volume>27</volume>:<page-range>344&#x02013;9</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1097/YCO.0000000000000086</pub-id>
</mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>SM</given-names></name>
<name><surname>Han</surname><given-names>C</given-names></name>
<name><surname>Bahk</surname><given-names>WM</given-names></name>
<name><surname>Lee</surname><given-names>SJ</given-names></name>
<name><surname>Patkar</surname><given-names>AA</given-names></name>
<name><surname>Masand</surname><given-names>PS</given-names></name>
<etal/>
</person-group>. <article-title>Addressing the side effects of contemporary antidepressant drugs: A comprehensive review</article-title>. <source>Chonnam Med J</source>. (<year>2018</year>) <volume>54</volume>:<page-range>101&#x02013;12</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.4068/cmj.2018.54.2.101</pub-id>
</mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Pan</surname><given-names>YJ</given-names></name>
<name><surname>Cheng</surname><given-names>IC</given-names></name>
<name><surname>Yeh</surname><given-names>LL</given-names></name>
<name><surname>Cho</surname><given-names>YM</given-names></name>
<name><surname>Feng</surname><given-names>J</given-names></name>
</person-group>. <article-title>Utilization of traditional Chinese medicine in patients treated for depression: a population-based study in Taiwan</article-title>. <source>Complement Therapies Med</source>. (<year>2013</year>) <volume>21</volume>:<page-range>215&#x02013;23</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.ctim.2013.03.003</pub-id>
</mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ye</surname><given-names>J</given-names></name>
<name><surname>Xiao</surname><given-names>A</given-names></name>
<name><surname>Yu</surname><given-names>L</given-names></name>
<name><surname>Zhou</surname><given-names>L</given-names></name>
</person-group>. <article-title>Attitude toward and practice of using traditional Chinese medicine in psychiatry: A mixed study of forty-nine leading psychiatrists in China</article-title>. <source>Eur J Integr Med</source>. (<year>2020</year>) <volume>37</volume>:<fpage>101142</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.eujim.2020.101142</pub-id>
</mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ruan</surname><given-names>J</given-names></name>
<name><surname>Chen</surname><given-names>S</given-names></name>
<name><surname>Liang</surname><given-names>J</given-names></name>
<name><surname>Ho</surname><given-names>F</given-names></name>
<name><surname>Chen</surname><given-names>C</given-names></name>
<name><surname>Liang</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>Traditional Chinese medicine-based integrated health interventions for depression: A systematic review and meta-analysis</article-title>. <source>J Clin Nurs</source>. (<year>2023</year>) <volume>32</volume>:<page-range>5632&#x02013;51</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/jocn.v32.17-18</pub-id>
</mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Song</surname><given-names>Z-G</given-names></name>
<name><surname>Zhou</surname><given-names>X-Q</given-names></name>
<name><surname>Yan</surname><given-names>D-M</given-names></name>
<name><surname>Tang</surname><given-names>LP</given-names></name>
<name><surname>Wang</surname><given-names>F</given-names></name>
<name><surname>Li</surname><given-names>B</given-names></name>
</person-group>. <article-title>Research progress on effective components and mechanisms of anti-depressive Chinese medicine</article-title>. <source>Zhongguo Zhong Yao Za Zhi</source>. (<year>2022</year>) <volume>47</volume>:<page-range>1184&#x02013;9</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.19540/j.cnki.cjcmm.20211122.202</pub-id>
</mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lam Ching</surname><given-names>W</given-names></name>
<name><surname>Li</surname><given-names>HJ</given-names></name>
<name><surname>Guo</surname><given-names>J</given-names></name>
<name><surname>Yao</surname><given-names>L</given-names></name>
<name><surname>Chau</surname><given-names>J</given-names></name>
<name><surname>Lo</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>Acupuncture for post-stroke depression: a systematic review and network meta-analysis</article-title>. <source>BMC Psychiatry</source>. (<year>2023</year>) <volume>23</volume>:<fpage>314</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1186/s12888-023-04749-1</pub-id>
<pub-id pub-id-type="pmid">37143014</pub-id>
</mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Xie</surname><given-names>Y</given-names></name>
<name><surname>Liu</surname><given-names>L</given-names></name>
<name><surname>Xie</surname><given-names>J</given-names></name>
</person-group>. <article-title>Clinical study on depression differentiated as yang deficiency treated with the combined therapy of ginger-isolated moxibustion and western medicine</article-title>. <source>Zhongguo zhen jiu</source>. (<year>2016</year>) <volume>36</volume>:<page-range>1252&#x02013;6</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.13703/j0255-2930.2016.12.007</pub-id>
</mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="webpage">
<person-group person-group-type="author">
<collab>China Society of Integrated Traditional Chinese and Western Medicine</collab>
</person-group>. <article-title>Guidelines of Integrative Chinese and Western Medicine for depressive disorders</article-title>(<year>2023</year>). Available online at: <uri xlink:href="https://www.cacm.org.cn/wp-content/uploads/2023/06/">https://www.cacm.org.cn/wp-content/uploads/2023/06/</uri>. (Accessed <date-in-citation content-type="access-date">July 13, 2023</date-in-citation>)</mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chan</surname><given-names>AW</given-names></name>
<name><surname>Tetzlaff</surname><given-names>JM</given-names></name>
<name><surname>G&#x000f8;tzsche</surname><given-names>PC</given-names></name>
<name><surname>Laupacis</surname><given-names>A</given-names></name>
<name><surname>G&#x000f8;tzsche</surname><given-names>PC</given-names></name>
<name><surname>Krle</surname><given-names>A-Jeri&#x00107; K</given-names></name>
<etal/>
</person-group>. <article-title>SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials</article-title>. <source>BMJ (Clinical Res ed)</source>. (<year>2013</year>) <volume>346</volume>:<fpage>e7586</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1136/bmj.e7586</pub-id>
</mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Janca</surname><given-names>A</given-names></name>
<name><surname>Hiller</surname><given-names>W</given-names></name>
</person-group>. <article-title>ICD-10 checklists&#x02013;a tool for clinicians&#x02019; use of the ICD-10 classification of mental and behavioral disorders</article-title>. <source>Compr Psychiatry</source>. (<year>1996</year>) <volume>37</volume>:<page-range>180&#x02013;7</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/S0010-440X(96)90034-6</pub-id>
</mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Folstein</surname><given-names>MF</given-names></name>
<name><surname>Folstein</surname><given-names>SE</given-names></name>
<name><surname>McHugh</surname><given-names>PR</given-names></name>
</person-group>. <article-title>Mini-mental state&#x0201d;. A practical method for grading the cognitive state of patients for the clinician</article-title>. <source>J Psychiatr Res</source>. (<year>1975</year>) <volume>12</volume>:<page-range>189&#x02013;98</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/0022-3956(75)90026-6</pub-id>
</mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>MacPherson</surname><given-names>H</given-names></name>
<name><surname>Altman</surname><given-names>DG</given-names></name>
<name><surname>Hammerschlag</surname><given-names>R</given-names></name>
<name><surname>Li</surname><given-names>Y</given-names></name>
<name><surname>Wu</surname><given-names>T</given-names></name>
<name><surname>White</surname><given-names>A</given-names></name>
<etal/>
</person-group>. <article-title>Revised STandards for reporting interventions in clinical trials of acupuncture (STRICTA): extending the CONSORT statement</article-title>. <source>J Evidence-Based Med</source>. (<year>2010</year>) <volume>3</volume>:<page-range>140&#x02013;55</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/j.1756-5391.2010.01086.x</pub-id>
</mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Arvidsdotter</surname><given-names>T</given-names></name>
<name><surname>Marklund</surname><given-names>B</given-names></name>
<name><surname>Taft</surname><given-names>C</given-names></name>
</person-group>. <article-title>Effects of an integrative treatment, therapeutic acupuncture and conventional treatment in alleviating psychological distress in primary care patients&#x02013;a pragmatic randomized controlled trial</article-title>. <source>BMC Complement Altern Med</source>. (<year>2013</year>) <volume>13</volume>:<fpage>308</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1186/1472-6882-13-308</pub-id>
<pub-id pub-id-type="pmid">24200100</pub-id>
</mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wickberg</surname><given-names>B</given-names></name>
<name><surname>Hwang</surname><given-names>CP</given-names></name>
</person-group>. <article-title>Counselling of postnatal depression: a controlled study on a population based Swedish sample</article-title>. <source>J Affect Disord</source>. (<year>1996</year>) <volume>39</volume>:<page-range>209&#x02013;16</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/0165-0327(96)00034-1</pub-id>
</mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Qaseem</surname><given-names>A</given-names></name>
<name><surname>Barry</surname><given-names>MJ</given-names></name>
<name><surname>Kansagara</surname><given-names>D</given-names></name>
</person-group>. <article-title>Nonpharmacologic versus pharmacologic treatment of adult patients with major depressive disorder: A clinical practice guideline from the American College of Physicians</article-title>. <source>Ann Internal Med</source>. (<year>2016</year>) <volume>164</volume>:<page-range>350&#x02013;9</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.7326/M15-2570</pub-id>
</mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Chinese Journal of General Practitioners</collab>
</person-group>. <article-title>Guideline for primary care of major depressive disorder</article-title>. <source>Chin J Gen Practitioners</source>. (<year>2021</year>) <volume>20</volume>:<page-range>1249&#x02013;60</page-range>.</mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hinton</surname><given-names>L</given-names></name>
<name><surname>La Frano</surname><given-names>E</given-names></name>
<name><surname>Harvey</surname><given-names>D</given-names></name>
<name><surname>Alfaro</surname><given-names>ED</given-names></name>
<name><surname>Kravitz</surname><given-names>R</given-names></name>
<name><surname>Smith</surname><given-names>A</given-names></name>
<etal/>
</person-group>. <article-title>Feasibility of a family-centered intervention for depressed older men in primary care</article-title>. <source>Int J Geriatr Psychiatry</source>. (<year>2019</year>) <volume>34</volume>:<page-range>1808&#x02013;14</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1002/gps.v34.12</pub-id>
</mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ghazisaeedi</surname><given-names>M</given-names></name>
<name><surname>Mahmoodi</surname><given-names>H</given-names></name>
<name><surname>Arpaci</surname><given-names>I</given-names></name>
<name><surname>Mehrdar</surname><given-names>S</given-names></name>
<name><surname>Barzegari</surname><given-names>S</given-names></name>
</person-group>. <article-title>Validity, reliability, and optimal cut-off scores of the WHO-5, PHQ-9, and PHQ-2 to screen depression among university students in Iran</article-title>. <source>Int J Ment Health Addict</source>. (<year>2022</year>) <volume>20</volume>:<page-range>1824&#x02013;33</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1007/s11469-021-00483-5</pub-id>
</mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Inagaki</surname><given-names>M</given-names></name>
<name><surname>Ohtsuki</surname><given-names>T</given-names></name>
<name><surname>Yonemoto</surname><given-names>N</given-names></name>
<name><surname>Kawashima</surname><given-names>Y</given-names></name>
<name><surname>Saitoh</surname><given-names>A</given-names></name>
<name><surname>Oikawa</surname><given-names>Y</given-names></name>
<etal/>
</person-group>. <article-title>Validity of the Patient Health Questionnaire (PHQ)-9 and PHQ-2 in general internal medicine primary care at a Japanese rural hospital: a cross-sectional study</article-title>. <source>Gen Hosp Psychiatry</source>. (<year>2013</year>) <volume>35</volume>:<page-range>592&#x02013;7</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.genhosppsych.2013.08.001</pub-id>
</mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Jia</surname><given-names>F</given-names></name>
<name><surname>Chen</surname><given-names>C-C</given-names></name>
</person-group>. <article-title>Emotional characteristics and time series analysis of Internet public opinion participants based on emotional feature words</article-title>. <source>Int J Adv Robotic Syst</source>. (<year>2020</year>) <volume>17</volume>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1177/1729881420904213</pub-id>
</mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zung</surname><given-names>WW</given-names></name>
</person-group>. <article-title>A self-rating depression scale</article-title>. <source>Arch Gen Psychiatry</source>. (<year>1965</year>) <volume>12</volume>:<fpage>63</fpage>&#x02013;<lpage>70</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1001/archpsyc.1965.01720310065008</pub-id>
<pub-id pub-id-type="pmid">14221692</pub-id>
</mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kroenke</surname><given-names>K</given-names></name>
<name><surname>Strine</surname><given-names>TW</given-names></name>
<name><surname>Spitzer</surname><given-names>RL</given-names></name>
<name><surname>Williams</surname><given-names>JB</given-names></name>
<name><surname>Berry</surname><given-names>JT</given-names></name>
<name><surname>Mokdad</surname><given-names>AH</given-names></name>
</person-group>. <article-title>The PHQ-8 as a measure of current depression in the general population</article-title>. <source>J Affect Disord</source>. (<year>2009</year>) <volume>114</volume>:<page-range>163&#x02013;73</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jad.2008.06.026</pub-id>
</mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Johns</surname><given-names>MW</given-names></name>
</person-group>. <article-title>A new method for measuring daytime sleepiness: the Epworth sleepiness scale</article-title>. <source>Sleep</source>. (<year>1991</year>) <volume>14</volume>:<page-range>540&#x02013;5</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1093/sleep/14.6.540</pub-id>
</mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Jung</surname><given-names>H</given-names></name>
<name><surname>von Sternberg</surname><given-names>K</given-names></name>
<name><surname>Davis</surname><given-names>K</given-names></name>
</person-group>. <article-title>Expanding a measure of mental health literacy: Development and validation of a multicomponent mental health literacy measure</article-title>. <source>Psychiatry Res</source>. (<year>2016</year>) <volume>243</volume>:<page-range>278&#x02013;86</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.psychres.2016.06.034</pub-id>
</mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zhi-jun</surname><given-names>M</given-names></name>
<name><surname>Zhi-yan</surname><given-names>C</given-names></name>
<name><surname>Ya-xin</surname><given-names>W</given-names></name>
</person-group>. <article-title>Reliability and validity of multicomponent mental health literacy measure-Chinese version in male military personnel</article-title>. <source>Chin J Public Health</source>. (<year>2021</year>) <volume>37</volume>:<fpage>86</fpage>&#x02013;<lpage>91</lpage>.</mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ware</surname><given-names>J</given-names><suffix>Jr.</suffix></name>
<name><surname>Kosinski</surname><given-names>M</given-names></name>
<name><surname>Keller</surname><given-names>SD</given-names></name>
</person-group>. <article-title>A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity</article-title>. <source>Med Care</source>. (<year>1996</year>) <volume>34</volume>:<page-range>220&#x02013;33</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1097/00005650-199603000-00003</pub-id>
</mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>T</given-names></name>
<name><surname>Wang</surname><given-names>J</given-names></name>
<name><surname>Xin</surname><given-names>C</given-names></name>
<name><surname>Kong</surname><given-names>L</given-names></name>
<name><surname>Wang</surname><given-names>C</given-names></name>
</person-group>. <article-title>Effect of memantine combined with citalopram on cognition of BPSD and moderate Alzheimer&#x02019;s disease: A clinical trial</article-title>. <source>Exp Ther Med</source>. (<year>2019</year>) <volume>17</volume>:<page-range>1625&#x02013;30</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.3892/etm.2018.7124</pub-id>
</mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>GJ</given-names></name>
<name><surname>Shi</surname><given-names>ZY</given-names></name>
<name><surname>Liu</surname><given-names>S</given-names></name>
<name><surname>Gong</surname><given-names>SH</given-names></name>
<name><surname>Liu</surname><given-names>JQ</given-names></name>
<name><surname>Liu</surname><given-names>JS</given-names></name>
</person-group>. <article-title>Clinical observation on treatment of depression by electro-acupuncture combined with Paroxetine</article-title>. <source>Chin J Integr Med</source>. (<year>2007</year>) <volume>13</volume>:<page-range>228&#x02013;30</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1007/s11655-007-0228-0</pub-id>
</mixed-citation></ref></ref-list></back></article>